In today's episode, I breakdown the ICPT NASH results, followed up by a quick take on SAGE and the latest buyout rumors. this is not investment advice Relevant links: http://ir.interceptpharma.com/news-releases/news-release-details/intercept-announces-positive-topline-results-pivotal-phase-3 https://www.sagerx.com/ www.breakingbiotech.com